Skip to content

Pulse Biosciences

US · PLSE #2388 by market cap Listed 2016
45.55 +1.14 +2.57%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/8/10
  • Rating change
    Needham Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $58
    Market Newswire · 2026/8/17
  • Rating change
    BTIG Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $70
    Market Newswire · 2026/9/23
  • Rating change
    CCORF Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $58
    Market Newswire · 2026/10/8
  • Rating change
    Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $55
    Market Newswire · 2026/10/13
  • Rating change
    Freedom Capital Markets Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $73
    Market Newswire · 2026/9/9
  • Rating change
    CCORF Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $43
    Market Newswire · 2026/8/12
  • Rating change
    Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $30
    Market Newswire · 2026/4/13
  • Rating change
    Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $35
    Market Newswire · 2026/7/28
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Pulse Biosciences (PLSE), OmniAb (OABI) and Halozyme (HALO)
    TipRanks · 2026/10/7
  • Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $65
    Market Newswire · 2026/11/6
  • Rating change
    Canaccord Genuity Keeps Their Buy Rating on Pulse Biosciences (PLSE)
    TipRanks · 2026/7/30
  • CCORF Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $74
    Market Newswire · 2026/11/6
  • Rating change
    CCORF Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $32
    Market Newswire · 2026/6/4
  • Rating change
    Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $60
    Market Newswire · 2026/10/13
  • BTIG Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $70
    Market Newswire · 2026/11/6
  • Earnings Flash (PLSE) Pulse Biosciences, Inc. Reports Q3 Revenue $400,000, Vs. FactSet Est of $521,000
    MT Newswires · 2026/11/6
  • Rating change
    CCORF Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $58
    Market Newswire · 2026/10/6
  • Earnings Preview: PLSE to Report Financial Results Post-market on November 05
    Market Newswire · 2026/10/31
  • Rating change
    CCORF Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $43
    Market Newswire · 2026/8/10
  • Rating change
    Oppenheimer Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $22
    Market Newswire · 2025/7/8
  • Rating change
    Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $22
    Market Newswire · 2025/11/6
  • Rating change
    Mizuho Securities Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $25
    Market Newswire · 2026/1/30
  • Rating change
    Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $30
    Market Newswire · 2026/2/6
  • BTIG Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $70
    Market Newswire · 2026/10/7

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Pulse Biosciences discussion 0 comments

Add a comment